These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30100073)

  • 1. Molecular Classification of Breast Cancer.
    Provenzano E; Ulaner GA; Chin SF
    PET Clin; 2018 Jul; 13(3):325-338. PubMed ID: 30100073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts in breast cancer genomics: An evidence based review by the CGC breast cancer working group.
    Geiersbach KB; Chen H; Emmadi R; Haskell GT; Lu X; Liu YJ; Swisshelm K
    Cancer Genet; 2020 Jun; 244():11-20. PubMed ID: 32087595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
    Tishchenko I; Milioli HH; Riveros C; Moscato P
    PLoS One; 2016; 11(6):e0158259. PubMed ID: 27341628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational Genomics: Practical Applications of the Genomic Revolution in Breast Cancer.
    Yates LR; Desmedt C
    Clin Cancer Res; 2017 Jun; 23(11):2630-2639. PubMed ID: 28572257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
    Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
    J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonfamilial breast cancer subtypes.
    Ringnér M; Staaf J; Jönsson G
    Methods Mol Biol; 2013; 973():279-95. PubMed ID: 23412797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes.
    Li J; Ivansson E; Klevebring D; Tobin NP; Lindström LS; Holm J; Prochazka G; Cristando C; Palmgren J; Törnberg S; Humphreys K; Hartman J; Frisell J; Rantalainen M; Lindberg J; Hall P; Bergh J; Grönberg H; Czene K
    Clin Cancer Res; 2017 May; 23(10):2584-2592. PubMed ID: 27587435
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular Phenotype, Multigene Assays, and the Locoregional Management of Breast Cancer.
    Braunstein LZ; Taghian AG
    Semin Radiat Oncol; 2016 Jan; 26(1):9-16. PubMed ID: 26617205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
    Li D; Xia H; Li ZY; Hua L; Li L
    Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic and genomic features of invasive lobular breast cancer.
    Desmedt C; Zoppoli G; Sotiriou C; Salgado R
    Semin Cancer Biol; 2017 Jun; 44():98-105. PubMed ID: 28400203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized therapy for breast cancer.
    De Abreu FB; Schwartz GN; Wells WA; Tsongalis GJ
    Clin Genet; 2014 Jul; 86(1):62-7. PubMed ID: 24635704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the clinical detection of heterogeneity in breast cancer.
    Song JL; Chen C; Yuan JP; Sun SR
    Cancer Med; 2016 Dec; 5(12):3475-3488. PubMed ID: 27774765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Genomic Landscape of Male Breast Cancers.
    Piscuoglio S; Ng CK; Murray MP; Guerini-Rocco E; Martelotto LG; Geyer FC; Bidard FC; Berman S; Fusco N; Sakr RA; Eberle CA; De Mattos-Arruda L; Macedo GS; Akram M; Baslan T; Hicks JB; King TA; Brogi E; Norton L; Weigelt B; Hudis CA; Reis-Filho JS
    Clin Cancer Res; 2016 Aug; 22(16):4045-56. PubMed ID: 26960396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating multiple omics data for the discovery of potential Beclin-1 interactions in breast cancer.
    Chen Y; Wang X; Wang G; Li Z; Wang J; Huang L; Qin Z; Yuan X; Cheng Z; Zhang S; Yin Y; He J
    Mol Biosyst; 2017 May; 13(5):991-999. PubMed ID: 28401970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic analysis of primary tumors and metastases in breast cancer.
    Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
    Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
    Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
    Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragments.
    Fu S; Cheng J; Wei C; Yang L; Xiao X; Zhang D; Stewart MD; Fu J
    Oncotarget; 2017 Jul; 8(27):43866-43877. PubMed ID: 28410206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
    Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
    BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
    Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
    Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.
    Karthik GM; Rantalainen M; Stålhammar G; Lövrot J; Ullah I; Alkodsi A; Ma R; Wedlund L; Lindberg J; Frisell J; Bergh J; Hartman J
    BMC Cancer; 2017 Nov; 17(1):802. PubMed ID: 29187174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.